Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • G Offline
    G Offline
    GeorgeBest
    wrote on sidst redigeret af
    #229

    Ja i tredie linie er det. Vincent Rajkumar har på Twitter meddelt at han vil bruge Sarclisa i Pom/Dex kombien hvis det er billigere...

    1 Reply Last reply
    0
    • G Offline
      G Offline
      GeorgeBest
      wrote on sidst redigeret af
      #230

      Sarclisa er kun godkendt til tredie linie plus patienter, så i første og anden linie er det ikke en trussel, og det er langt det største marked

      1 Reply Last reply
      0
      • G Offline
        G Offline
        GeorgeBest
        wrote on sidst redigeret af
        #231

        Nogen der ved hvornår Sarclisa kan blive godkendt i 1. og 2. linie?

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #232
          1. linje dette her fase 3 - Ikema: https://www.clinicaltrials.gov/ct2/show/NCT03275285?term=isatuximab+mm&draw=2&rank=4
          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #233

            Det eneste 1. linje jeg har kunnet finde er dette fase 1: https://www.clinicaltrials.gov/ct2/show/NCT02513186?term=isatuximab+mm&draw=2&rank=2

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #234

              Så Ikema i 2. linje bliver det næste med primary completion til november og tidligst godkendelse sidst i 2021.

              1 Reply Last reply
              0
              • G Offline
                G Offline
                GeorgeBest
                wrote on sidst redigeret af
                #235

                Tak Bulder

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #236

                  this NKTCL trial was recently completed; should we expect a Ph III trial to be started? https://clinicaltrials.gov/ct2/show/NCT02927925?term=NKTCL+AND+daratumumab&draw=2&rank=1

                  1 Reply Last reply
                  0
                  • G Offline
                    G Offline
                    GeorgeBest
                    wrote on sidst redigeret af
                    #237

                    There were some years ago stories about fantastic outcome for some patients with NKTCL who received dara. But since then it has been quite.

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #238

                      Conclusions: DARA 16 mg/kg was well tolerated with no new safety concerns, and only 2 patients discontinuing due to TEAEs. DARA monotherapy demonstrated an encouraging response rate (ORR: 25%) in pts with R/R NKTCL and warrants further study in this poor prognosis pt population. https://ashpublications.org/blood/article/134/Supplement_1/1568/427350/Daratumumab-Monotherapy-for-Patients-with-Relapsed

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #239

                        Spørgsmålet er så om det var opmuntrende nok

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #240

                          1513.5 low vs last weeks' 1504.5 ; lets hope it will turn into a double bottom....

                          1 Reply Last reply
                          0
                          • Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktør
                            wrote on sidst redigeret af
                            #241

                            Genmab is proud to be on the 2020NJBIZ BestPlacesNJ to work list: https://njbiz.com/best-places-to-work-in-nj-2020/

                            1 Reply Last reply
                            0
                            • nohopeN Offline
                              nohopeN Offline
                              nohope
                              wrote on sidst redigeret af
                              #242

                              Hmm - mon ikke det er sådan en liste over - lidet at bestille og meget at fortjene top ti?

                              1 Reply Last reply
                              0
                              • nohopeN Offline
                                nohopeN Offline
                                nohope
                                wrote on sidst redigeret af
                                #243

                                Deres excellence, det maatte være et embede, hvorved der var meget at fortjene og lidet at bestille; thi dertil føler jeg mig mest oplagt.

                                1 Reply Last reply
                                0
                                • SolsenS Offline
                                  SolsenS Offline
                                  Solsen
                                  wrote on sidst redigeret af
                                  #244

                                  Lol

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #245

                                    🙂

                                    1 Reply Last reply
                                    0
                                    • bongobobB Offline
                                      bongobobB Offline
                                      bongobob
                                      wrote on sidst redigeret af
                                      #246

                                      Se seneste slide ware fra Genmab side 33. DR5/DR5 er MEGET potent https://ir.genmab.com/static-files/50a5c114-5126-45a8-9d6f-17b883705a16

                                      1 Reply Last reply
                                      0
                                      • bongobobB Offline
                                        bongobobB Offline
                                        bongobob
                                        wrote on sidst redigeret af
                                        #247

                                        Bla dette: 23% tumor shrinkage after single dose in a patient with CRC

                                        1 Reply Last reply
                                        0
                                        • bongobobB Offline
                                          bongobobB Offline
                                          bongobob
                                          wrote on sidst redigeret af
                                          #248

                                          Hørte Jan tale om det men har ikke set det på skrift før

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger